SEC Form 4 · accession 0001179110-18-007429
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darcy G Mott
Officer — Executive VP and CFO
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 21, 2018 | M | 12,500 | $1.25 | A | 111,500 | D | |
| Common StockF2 | May 21, 2018 | S | 9,500 | $73.9302 | D | 102,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $1.25 | May 21, 2018 | M | 12,500 | D | — | Aug 8, 2021 | Common Stock | 12,500 | 0 | D |
| Stock Option (right to buy)F3 | $14.00 | holding | — | — | — | — | Jul 30, 2024 | Common Stock | 60,000 | 60,000 | D |
| Stock Option (right to buy)F4 | $41.28 | holding | — | — | — | — | Mar 27, 2027 | Common Stock | 19,897 | 19,897 | D |
| Stock Option (right to buy)F5 | $25.39 | holding | — | — | — | — | Mar 26, 2025 | Common Stock | 25,000 | 25,000 | D |
| Stock Option (right to buy)F6 | $61.72 | holding | — | — | — | — | Mar 27, 2028 | Common Stock | 14,228 | 14,228 | D |
Explanation of responses
- F1The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.51 to $74.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- F3The option is immediately exercisable.
- F4The option is exercisable as to 4,974 shares. The remaining shares become exercisable in two annual installments of 4,974 shares on March 27, 2019, and 2020 and in one installment of 4,975 shares on March 27, 2021.
- F5The option is exercisable as to 18,750 shares. The remaining shares become exercisable on March 26, 2019.
- F6The option becomes exercisable in four equal installments of 3,557 shares on March 27, 2019, 2020, 2021, and 2022.